Keyphrases
CD8+ T Cells
67%
Memory CD8+ T Cells
43%
COVID-19
32%
Tumor-specific
30%
Irreversible Electroporation
29%
T Cells
21%
T Cell Response
16%
Tyrosinase-related Protein 2
16%
Self-tolerance
16%
Tumor Control
16%
P2X7 Receptor (P2X7R)
16%
Solid Tumors
16%
Adoptive Cell Therapy
16%
Checkpoint Immunotherapy
16%
Cryosurgery
16%
Cancer Antigen
16%
Tissue Damage
16%
Resident Memory
16%
Protective Immunity
16%
Tissue-resident
16%
Antigen-specific
16%
MRNA Vaccine
16%
Lung
16%
Tumor Antigen
16%
Memory CD4 T Cells
16%
Prostate Cancer
16%
Small Activating RNA (saRNA)
16%
Intranasal
16%
Epitope
16%
Cell Response
16%
Vaccination
16%
Respiratory mucosa
16%
Tumor
14%
Non-lymphoid Tissues
12%
Focal Therapy
10%
Healthy Tissue
10%
Memory T Cells
10%
Intramuscular Immunization
10%
Neutralizing Abs
10%
Cellular Immunity
10%
K18-hACE2 Mice
10%
Humoral Immunity
10%
Nucleoprotein
10%
Recirculating
9%
Immune System
8%
Tumor Challenge
8%
Tumor Destruction
8%
Anti-CTLA-4
8%
Immune Checkpoint Inhibitors
8%
Immunization
8%
Immunology and Microbiology
Cytotoxic T-Cell
100%
Mouse
49%
T Cell
47%
Vaccination Policy
38%
Vaccine Efficacy
36%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Electroporation
32%
Tumor Antigen
32%
Immunotherapy
25%
Epitope
20%
Immune Tolerance
16%
Spike
16%
T-Helper Cell
16%
Virus Nucleocapsid
16%
Prostate
16%
Wild Type
16%
COVID-19
14%
Nucleoprotein
14%
Respiratory Mucosa
13%
Memory T Cell
12%
Lymphoid Tissue
12%
Gene Expression
10%
CD25
10%
Immune System
9%
Adoptive Immunity
9%
Humoral Immunity
9%
CTLA-4
8%
Tumor Immunity
8%
Immunostimulation
8%
Lymph Node
8%
Stem Cell
8%
T Cell Activation
6%
Cell Lysate
6%
Pulse Rate
6%
Cancer Immunotherapy
6%
Cross-Reactivity
5%
Adenoviridae
5%
Virus Spike
5%
Transgenic Mouse
5%
Immunopathology
5%
Vitiligo
5%
Melanocyte
5%
Precursor
5%
Medicine and Dentistry
Tumor Antigen
32%
Irreversible Electroporation
29%
Immunotherapy
24%
Cytotoxic T-Cell
18%
T-Cell Response
16%
Cryosurgery
16%
Neoplasm
16%
Prostate Cancer
16%
Specific Tumor
12%
Lymphatic Tissue
12%
Immune System
8%
CTLA-4
8%
Immune Checkpoint Inhibitor
8%
T Cell Activation
5%
Pulse Rate
5%
